Advertisement

NLS Scandinavian Biopharma

Clinical Trials - March 1, 2021

First child vaccinated in Scandinavian Biopharma’s Phase IIb Gambia trial

The first child has been vaccinated in The Gambia with the company’s ETEC vaccine candidate, ETVAX. It is a randomised, placebo-controlled, and double-blind phase IIB study. The study will include about 5,000 children aged 6-23 months. The overall goal of the study is to investigate the protective effect against moderate to severe diarrhoea caused by […]

In a new job - December 14, 2020

Scandinavian Biopharma recruits Clinical Operations Manager

Scandinavian Biopharma strengthens the organization in Clinical Operations through the recruitment of the pharmacist Christin Hindrika Strid, as Clinical Operations Manager. The company is in a late-stage clinical development phase and has an ambitious clinical development programme with several ongoing clinical studies for the ETEC vaccine candidate ETVAX. Together with Anna Hill, Christin will be […]

In a new job - December 9, 2020

Scandinavian Biopharma appoints VP Regulatory Affairs

Scandinavian Biopharma strengthens the organization in regulatory affairs through the recruitment of Åsa Dahlbäck as the new VP Regulatory Affairs. Åsa has more than 30 years of experience in the biotech industry and extensive knowledge of regulatory activities in biopharmaceutical products and biological drug development projects. She previously has had senior positions at, among others, […]

Agreement - October 13, 2020

Scandinavian Biopharma enters into agreement with USAMRAA

Scandinavian Biopharma has entered into an agreement with the United States Army Medical Research Acquisition Activity (USAMRAA) to support the production and development of the vaccine, with the long-term goal of preventing bacterial diarrhoea in war fighters. In April this year, SBH announced the preliminary findings from a Phase 2b study of the oral vaccine […]

In a new job - October 10, 2020

Scandinavian Biopharma appoints new Key Account Manager

Scandinavian Biopharma has recruited Erika Söderström to the new position as Key Account Manager. Söderström is a nurse by education and has for the past 20 years worked in different positions within the vaccine-, pharmaceutical- and medtech-industry. Focused on vaccines “Last year we were awarded and qualified as “Gazelle company” by Dagens Industri, DI. This […]

Agreement - September 3, 2020

Scandinavian Biopharma enters distribution agreement

Scandinavian Biopharma has entered into a distribution agreement with Bio Products Laboratory Limited (BPL), a manufacturer of plasma-derived protein therapies, for their factor X deficiency product Coagadex. Coagadex is a treatment for factor X deficiency bleeding disorder in Europe. Coagadex is indicated for the treatment and prophylaxis of bleeding episodes and for perioperative management in […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.